Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Long-Term Deferred Tax (2018 - 2021)

China SXT Pharmaceuticals (SXTC) has 4 years of Long-Term Deferred Tax data on record, last reported at $321444.0 in Q1 2021.

  • For Q1 2021, Long-Term Deferred Tax rose 184.87% year-over-year to $321444.0; the TTM value through Mar 2021 reached $321444.0, up 184.87%, while the annual FY2021 figure was $321444.0, 184.87% up from the prior year.
  • Long-Term Deferred Tax reached $321444.0 in Q1 2021 per SXTC's latest filing, up from $112839.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $321444.0 in Q1 2021 and bottomed at $6174.0 in Q1 2018.
  • Average Long-Term Deferred Tax over 4 years is $113490.2, with a median of $63171.5 recorded in 2019.
  • Peak YoY movement for Long-Term Deferred Tax: soared 118.72% in 2019, then soared 735.6% in 2020.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $6174.0 in 2018, then skyrocketed by 118.72% to $13504.0 in 2019, then soared by 735.6% to $112839.0 in 2020, then soared by 184.87% to $321444.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $321444.0 in Q1 2021, $112839.0 in Q1 2020, and $13504.0 in Q1 2019.